Clinical Trial Update: Megestrol Acetate for Fatigue Management in T-DXd Treated Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Megestrol Acetate for fatigue management in patients with advanced/metastatic breast cancer treated with trastuzumab deruxtecan; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Megestrol acetate (megestrol acetate)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Advanced/Metastatic Breast Cancer, HER2+, Low, or Ultralow Advanced/Metastatic Breast Cancer | Phase 3 | Status: NOT_YET_RECRUITING